| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,356 |
17,874 |
$9.19M |
| 0450 |
Emergency room services |
20,612 |
19,081 |
$6.37M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,715 |
3,634 |
$2.86M |
| 99499 |
|
7,779 |
6,577 |
$2.51M |
| 99199 |
Unlisted special service, procedure or report |
1,585 |
1,399 |
$1.20M |
| 80053 |
Comprehensive metabolic panel |
24,893 |
23,092 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,437 |
3,341 |
$1.01M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,487 |
11,572 |
$854K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,807 |
6,283 |
$810K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,400 |
2,178 |
$734K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,868 |
8,300 |
$733K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,098 |
25,035 |
$545K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,099 |
1,082 |
$503K |
| 71045 |
Radiologic examination, chest; single view |
9,417 |
9,004 |
$484K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,180 |
1,104 |
$478K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,070 |
6,573 |
$332K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,220 |
7,043 |
$280K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
446 |
442 |
$262K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
647 |
631 |
$240K |
| 0360 |
|
209 |
162 |
$230K |
| 83690 |
|
10,098 |
9,578 |
$227K |
| 84484 |
|
7,694 |
7,264 |
$225K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,467 |
5,225 |
$223K |
| 81001 |
|
13,777 |
13,124 |
$208K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,757 |
1,650 |
$196K |
| Z7502 |
|
4,265 |
4,210 |
$157K |
| 87040 |
|
1,727 |
1,627 |
$134K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,396 |
1,380 |
$133K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,312 |
3,162 |
$110K |
| 71046 |
Radiologic examination, chest; 2 views |
1,615 |
1,541 |
$97K |
| 82962 |
|
5,030 |
4,346 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,605 |
2,487 |
$92K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,155 |
1,109 |
$85K |
| 80305 |
|
1,172 |
1,132 |
$80K |
| 84703 |
|
5,844 |
5,583 |
$77K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
456 |
445 |
$75K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
591 |
583 |
$67K |
| 83735 |
|
3,572 |
3,384 |
$62K |
| 85610 |
|
4,098 |
3,910 |
$60K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,147 |
1,945 |
$55K |
| 84702 |
|
1,668 |
1,560 |
$55K |
| 82077 |
|
1,343 |
1,296 |
$48K |
| 76830 |
Ultrasound, transvaginal |
366 |
356 |
$47K |
| 73030 |
|
576 |
543 |
$42K |
| 73562 |
|
736 |
670 |
$42K |
| 0710 |
|
195 |
192 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,561 |
1,532 |
$41K |
| 73630 |
|
661 |
624 |
$41K |
| 83880 |
|
1,653 |
1,581 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
644 |
636 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,095 |
1,028 |
$34K |
| 83605 |
|
2,252 |
2,127 |
$34K |
| 87081 |
|
1,332 |
1,306 |
$34K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
233 |
232 |
$27K |
| 85379 |
|
1,070 |
1,045 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
536 |
440 |
$26K |
| 85730 |
|
2,154 |
2,098 |
$24K |
| 93971 |
|
101 |
98 |
$23K |
| 73610 |
|
314 |
307 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
619 |
610 |
$21K |
| 87186 |
|
1,545 |
1,488 |
$20K |
| 87631 |
|
429 |
422 |
$18K |
| 70496 |
|
39 |
39 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,401 |
1,369 |
$17K |
| 76801 |
|
120 |
109 |
$17K |
| 73130 |
|
261 |
245 |
$17K |
| 70498 |
|
40 |
40 |
$17K |
| 87077 |
|
1,653 |
1,592 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,558 |
7,235 |
$14K |
| 70486 |
|
28 |
27 |
$14K |
| 80143 |
|
314 |
307 |
$13K |
| 80179 |
|
293 |
288 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
66 |
51 |
$11K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
24 |
24 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
2,835 |
2,475 |
$9K |
| 81003 |
|
1,002 |
988 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,725 |
2,540 |
$8K |
| 86900 |
|
294 |
281 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
70 |
64 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,222 |
2,103 |
$8K |
| 72100 |
|
104 |
104 |
$7K |
| 72131 |
|
24 |
24 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,716 |
6,294 |
$6K |
| 86140 |
|
527 |
511 |
$6K |
| 86901 |
|
294 |
281 |
$6K |
| 84145 |
|
273 |
265 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
195 |
192 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,606 |
1,462 |
$5K |
| 82550 |
|
302 |
294 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,530 |
1,479 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
161 |
155 |
$5K |
| 97139 |
|
220 |
70 |
$5K |
| 71250 |
|
25 |
25 |
$5K |
| 0258 |
|
566 |
531 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
53 |
51 |
$4K |
| 96376 |
|
113 |
106 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
787 |
696 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
338 |
325 |
$3K |
| 90715 |
|
130 |
125 |
$3K |
| 73110 |
|
29 |
28 |
$3K |
| 87510 |
|
153 |
152 |
$2K |
| 87660 |
|
153 |
152 |
$2K |
| 87480 |
|
153 |
152 |
$2K |
| 73080 |
|
25 |
25 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
176 |
168 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,155 |
1,101 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
609 |
601 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,102 |
1,056 |
$2K |
| 74018 |
|
40 |
36 |
$2K |
| 80061 |
Lipid panel |
590 |
582 |
$2K |
| 84439 |
|
221 |
217 |
$2K |
| 85652 |
|
246 |
241 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
111 |
41 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
533 |
527 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
903 |
880 |
$1K |
| 87070 |
|
66 |
65 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,140 |
1,087 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
797 |
747 |
$972.29 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
544 |
522 |
$918.72 |
| 88304 |
|
37 |
37 |
$875.59 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
89 |
88 |
$869.69 |
| 82553 |
|
32 |
26 |
$854.05 |
| 85027 |
|
101 |
97 |
$678.66 |
| 82248 |
|
43 |
42 |
$503.87 |
| 73502 |
|
15 |
14 |
$471.00 |
| 87205 |
|
55 |
54 |
$371.56 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
351 |
333 |
$347.46 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
42 |
41 |
$328.96 |
| 82728 |
|
31 |
31 |
$323.28 |
| 83615 |
|
27 |
27 |
$314.05 |
| J3360 |
Injection, diazepam, up to 5 mg |
13 |
12 |
$286.71 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
92 |
92 |
$245.23 |
| 86850 |
|
13 |
13 |
$222.76 |
| 82150 |
|
13 |
12 |
$216.62 |
| J3490 |
Unclassified drugs |
13 |
13 |
$154.98 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
46 |
45 |
$150.46 |
| 82140 |
|
13 |
12 |
$132.20 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
13 |
$97.29 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
12 |
12 |
$66.79 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
41 |
38 |
$59.18 |
| J1630 |
Injection, haloperidol, up to 5 mg |
38 |
36 |
$49.76 |
| 83540 |
|
13 |
12 |
$40.93 |
| 82607 |
|
12 |
12 |
$21.03 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
50 |
49 |
$0.01 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
24 |
24 |
$0.00 |